HIGHLIGHTS
- who: Christina Schenkl and collaborators from the Department of Cardiothoracic Surgery, University Hospital Jena, Friedrich Schiller University of Jena, Am Klinikum, Jena, Germany have published the paper: The IGF-1R Inhibitor NVP-AEW541 Causes Insulin- Independent and Reversible Cardiac Contractile Dysfunction, in the Journal: Biomedicines 2022, 10, 2022. of /2022/
- how: Parametric data were analyzed using a one-way analysis of variance or a student t-test where appropriate.
SUMMARY
Its antitumor activity has been proven in_vitro and in_vivo and shows promising therapeutic potential. The specific impact of NVP-AEW541 application . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.